Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Rev Neurol ; 36(7): 632-5, 2003.
Article in Spanish | MEDLINE | ID: mdl-12666043

ABSTRACT

INTRODUCTION: Aspergillosis is the second fungemia after candidiasis that affects the central nervous system of immunodeppresed and immunocompetent humans. The literature reports nearly always compromised adults. CASE REPORTS: Two pediatric cases of central nervous system aspergillosis with different clinical course are presented. The first of them, is a immunocompetent person in whom a granulomatous disease of the central nervous system was suspected. The cultivation of stereotaxic biopsy reported thin septated hyphae. After 42 days of treatment with itraconazol the patient recovered completely. The second patient, had an acute lymphoblastic leukemia and developed a widespread aspergillosis including the central nervous system. In spite of antifungic treatment for 63 days, he died of heart failure. CONCLUSIONS: Diagnosis of aspergillosis is difficult because of the poor specificity of the neuroimages, cerebrospinal fluid and complementary labs. The images are indistinguishable from acute ischemia infarcts and later those images change to abscesses. Direct KOH staining and the cultivation of biopsed samples confirmed the diagnosis of aspergillosis. An aggressive treatment with amphotericin B and itraconazol is recommended, but high mortality is suspected. Diagnosis, neuroimaging, clinical evolution and treatment are discussed.


Subject(s)
Neuroaspergillosis/diagnostic imaging , Neuroaspergillosis/pathology , Adult , Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Aspergillus/metabolism , Brain/diagnostic imaging , Brain/pathology , Child, Preschool , Diagnosis, Differential , Fatal Outcome , Humans , Itraconazole/therapeutic use , Male , Neuroaspergillosis/drug therapy , Prognosis , Radiography
SELECTION OF CITATIONS
SEARCH DETAIL